Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Apr 8;19(1):45.
doi: 10.1186/s13014-024-02404-x.

Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer

Affiliations
Multicenter Study

Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer

Philip A Wheeler et al. Radiat Oncol. .

Abstract

Background: Current automated planning solutions are calibrated using trial and error or machine learning on historical datasets. Neither method allows for the intuitive exploration of differing trade-off options during calibration, which may aid in ensuring automated solutions align with clinical preference. Pareto navigation provides this functionality and offers a potential calibration alternative. The purpose of this study was to validate an automated radiotherapy planning solution with a novel multi-dimensional Pareto navigation calibration interface across two external institutions for prostate cancer.

Methods: The implemented 'Pareto Guided Automated Planning' (PGAP) methodology was developed in RayStation using scripting and consisted of a Pareto navigation calibration interface built upon a 'Protocol Based Automatic Iterative Optimisation' planning framework. 30 previous patients were randomly selected by each institution (IA and IB), 10 for calibration and 20 for validation. Utilising the Pareto navigation interface automated protocols were calibrated to the institutions' clinical preferences. A single automated plan (VMATAuto) was generated for each validation patient with plan quality compared against the previously treated clinical plan (VMATClinical) both quantitatively, using a range of DVH metrics, and qualitatively through blind review at the external institution.

Results: PGAP led to marked improvements across the majority of rectal dose metrics, with Dmean reduced by 3.7 Gy and 1.8 Gy for IA and IB respectively (p < 0.001). For bladder, results were mixed with low and intermediate dose metrics reduced for IB but increased for IA. Differences, whilst statistically significant (p < 0.05) were small and not considered clinically relevant. The reduction in rectum dose was not at the expense of PTV coverage (D98% was generally improved with VMATAuto), but was somewhat detrimental to PTV conformality. The prioritisation of rectum over conformality was however aligned with preferences expressed during calibration and was a key driver in both institutions demonstrating a clear preference towards VMATAuto, with 31/40 considered superior to VMATClinical upon blind review.

Conclusions: PGAP enabled intuitive adaptation of automated protocols to an institution's planning aims and yielded plans more congruent with the institution's clinical preference than the locally produced manual clinical plans.

Keywords: AI; Automation; IMRT; MCO; Multi-institutional; Pareto; Prostate cancer; Radiotherapy; Treatment planning; VMAT.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Pareto navigation calibration interface. Navigation is performed using the slider bars (top left), with the dose distribution (top centre) and DVH (top right– solid line) updated in real time within RayStation’s evaluation module. During navigation the operator can set the navigated distribution as a reference distribution (bottom centre) and DVH (top right– dotted line) to aid in the decision making. In this example the navigated position represents a solution where the rectum is spared at the expense of homogeneity and conformality (Cal1) with the reference distribution representative of the final calibration for IA (Cal2). The corresponding Cal2 slider positions are provided for reference (bottom left) and isodose legends have been enhanced for clarity. ROIs: rectum (brown), bladder (yellow), external (blue), PTV60 (pink), PTV57.5 (red) and PTV48 (orange)
Fig. 2
Fig. 2
Pareto front representations of the three navigated trade-offs (rectum Dmean, HIPTV60 and CIPTV48) demonstrating the dosimetric impact of two differently balanced calibrations (Cal1 & Cal2) on novel patients in the IA calibration dataset. Data from the navigation patient (Patient 1) is presented for reference, with Cal1 and Cal2 data points encompassed by the red and blue boxes respectively
Fig. 3
Fig. 3
1–1 plots comparing VMATAuto and VMATClinical across a range of OAR and PTV dose metrics for both institutions. Unity line is presented for reference and represents equivalence between the two techniques

References

    1. Hussein M, Heijmen BJM, Verellen D, Nisbet A. Automation in intensity modulated radiotherapy treatment planning—a review of recent innovations. Br J Radiol. 2018;91:20180270. doi: 10.1259/bjr.20180270. - DOI - PMC - PubMed
    1. Yuan L, Ge Y, Lee WR, Yin FF, Kirkpatrick JP, Wu QJ. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans. Med Phys. 2012;39:6868. doi: 10.1118/1.4757927. - DOI - PubMed
    1. Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL. Predicting dose-volume histograms for organs-at-risk in IMRT planning. Med Phys. 2012;39:7446–61. doi: 10.1118/1.4761864. - DOI - PubMed
    1. Babier A, Boutilier JJ, McNiven AL, Chan TCY. Knowledge-based automated planning for oropharyngeal cancer. Med Phys. 2018;45:2875–83. doi: 10.1002/mp.12930. - DOI - PubMed
    1. McIntosh C, Purdie TG. Voxel-based dose prediction with multi-patient atlas selection for automated radiotherapy treatment planning. Phys Med Biol. 2017;62:415–31. doi: 10.1088/1361-6560/62/2/415. - DOI - PubMed

Publication types